NTLA
Intellia Therapeutics, Inc. · Healthcare
EVP and Chief Medical Officer David Lebwohl sold $118K of Intellia Therapeutics, Inc.
Sold$117,964
$112.24Price
1,051Shares
−4%Stake
What NTLA did after the filing
- The stock from Thu, Mar 3 close, $70.97
- −15.6%
- S&P 500, same days
- +0.8%
Measured over 30 trading days, to the Apr 14 close.
Traded Sat, Jan 1. Filed Thu, Mar 3, 3:00 PM ET, during the session. Returns use the Mar 3 close and the Apr 14 close. Not investment advice.